Literature DB >> 12145099

Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.

Annette Hambrock1, Cornelia Löffler-Walz, Ulrich Quast.   

Abstract

1: ATP-sensitive K(+) channels are composed of pore-forming subunits Kir6.2 and of sulphonylurea receptors (SURs); the latter are the target of the hypoglycaemic sulphonylureas like glibenclamide. Here, we report on the negative allosteric modulation by MgATP and MgADP of glibenclamide binding to SUR1 and to SUR2 mutants with high glibenclamide affinity, SUR2A(Y1206S) and SUR2B(Y1206S). 2: ATP, in the presence of an ATP-regenerating system to oppose hydrolysis during incubation, inhibited glibenclamide binding to SUR1 and SUR2B(Y1206S) by approximately 60%, to SUR2A(Y1206S) by 21%). Inhibition curves for the SUR2(Y1206S) isoforms were monophasic with IC(50) values of 5-10 microM; the curve for SUR1 was biphasic (IC(50) values 4.7 and 1300 microM). 3: Glibenclamide inhibition curves for ADP, performed in the presence of an ATP-consuming system to oppose ATP formation from ADP, were generally shifted rightwards and showed positive cooperativity, in particular with the SUR2(Y1206S) isoforms. 4: In the absence of the coupled enzyme systems, inhibition curves of MgATP or MgADP were generally shifted leftwards. This indicated synergy of MgATP and MgATP in acting together. 5: Coexpression of SUR1 and SUR2B(Y1206S) with Kir6.2 reduced both potency and efficacy of ATP in inhibiting glibenclamide binding; this was particularly marked for Kir6.2/SUR1. 6: The data show (a) that the inhibitory effects of ATP and ADP on glibenclamide binding differ from one another, (b) that they depend on the SUR subtype, and (c) that they are weakened by coexpression with Kir6.2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145099      PMCID: PMC1573429          DOI: 10.1038/sj.bjp.0704801

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

Review 1.  New windows on the mechanism of action of K(ATP) channel openers.

Authors:  F M Ashcroft; F M Gribble
Journal:  Trends Pharmacol Sci       Date:  2000-11       Impact factor: 14.819

2.  C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.

Authors:  T Matsuoka; K Matsushita; Y Katayama; A Fujita; K Inageda; M Tanemoto; A Inanobe; S Yamashita; Y Matsuzawa; Y Kurachi
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

3.  On the mechanism of ADP-induced alteration of sulphonylurea sensitivity in cardiac ATP-sensitive K(+) channels.

Authors:  A Miyamura; M Kakei; K Ichinari; M Okamura; N Oketani; C Tei
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.

Authors:  A Hambrock; C Löffler-Walz; U Russ; U Lange; U Quast
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

5.  ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex.

Authors:  M Bienengraeber; A E Alekseev; M R Abraham; A J Carrasco; C Moreau; M Vivaudou; P P Dzeja; A Terzic
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

6.  Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.

Authors:  F Reimann; F M Gribble; F M Ashcroft
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

7.  Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels.

Authors:  D K Song; F M Ashcroft
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

8.  Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.

Authors:  U Russ; A Hambrock; F Artunc; C Löffler-Walz; Y Horio; Y Kurachi; U Quast
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

9.  Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.

Authors:  M Matsuo; K Tanabe; N Kioka; T Amachi; K Ueda
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

10.  Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.

Authors:  A Hambrock; C Löffler-Walz; Y Kurachi; U Quast
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

View more
  29 in total

1.  Binding and effect of K ATP channel openers in the absence of Mg2+.

Authors:  Ulrich Russ; Ulf Lange; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

2.  Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.

Authors:  Frank Reimann; Michael Dabrowski; Phillippa Jones; Fiona M Gribble; Frances M Ashcroft
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

Review 3.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

Review 4.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Authors:  Damian Stephan; Eva Stauss; Ulf Lange; Holger Felsch; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Russ; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

6.  Structurally distinct ligands rescue biogenesis defects of the KATP channel complex via a converging mechanism.

Authors:  Prasanna K Devaraneni; Gregory M Martin; Erik M Olson; Qing Zhou; Show-Ling Shyng
Journal:  J Biol Chem       Date:  2015-01-30       Impact factor: 5.157

7.  Cantu syndrome-associated SUR2 (ABCC9) mutations in distinct structural domains result in KATP channel gain-of-function by differential mechanisms.

Authors:  Conor McClenaghan; Alex Hanson; Monica Sala-Rabanal; Helen I Roessler; Dragana Josifova; Dorothy K Grange; Gijs van Haaften; Colin G Nichols
Journal:  J Biol Chem       Date:  2017-12-22       Impact factor: 5.157

8.  Fluorescent flavonoids for endoplasmic reticulum cell imaging.

Authors:  Lucas McDonald; Bin Liu; Alexandra Taraboletti; Kyle Whiddon; Leah P Shriver; Michael Konopka; Qin Liu; Yi Pang
Journal:  J Mater Chem B       Date:  2016-11-23       Impact factor: 6.331

9.  Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.

Authors:  Tobias Amann; Sophie Schell; Petra Kühner; Marcus Winkler; Mathias Schwanstecher; Ulrich Russ; Ulrich Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-30       Impact factor: 3.000

10.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.